Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 9 studies | 46% ± 18% | |
glutamatergic neuron | 9 studies | 38% ± 21% | |
oligodendrocyte precursor cell | 9 studies | 25% ± 7% | |
interneuron | 6 studies | 45% ± 19% | |
neuron | 4 studies | 23% ± 8% | |
endothelial cell | 4 studies | 34% ± 19% | |
GABAergic interneuron | 3 studies | 49% ± 14% | |
retinal pigment epithelial cell | 3 studies | 29% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 34% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 729.76 | 577 / 578 | 86% | 13.27 | 998 / 1155 |
brain | 97% | 1611.30 | 2563 / 2642 | 89% | 15.68 | 624 / 705 |
adrenal gland | 100% | 760.14 | 257 / 258 | 69% | 11.86 | 159 / 230 |
kidney | 73% | 230.39 | 65 / 89 | 71% | 21.62 | 642 / 901 |
thymus | 98% | 554.88 | 640 / 653 | 41% | 3.19 | 246 / 605 |
breast | 58% | 208.72 | 268 / 459 | 70% | 9.61 | 787 / 1118 |
bladder | 52% | 188.67 | 11 / 21 | 76% | 11.45 | 383 / 504 |
skin | 50% | 600.08 | 903 / 1809 | 78% | 9.75 | 368 / 472 |
esophagus | 42% | 243.76 | 611 / 1445 | 85% | 14.93 | 156 / 183 |
intestine | 49% | 331.19 | 473 / 966 | 73% | 9.55 | 384 / 527 |
stomach | 49% | 133.26 | 177 / 359 | 62% | 7.36 | 178 / 286 |
uterus | 8% | 25.70 | 14 / 170 | 92% | 17.62 | 423 / 459 |
spleen | 100% | 1646.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 14.97 | 44 / 45 |
prostate | 35% | 85.39 | 86 / 245 | 59% | 4.78 | 295 / 502 |
pancreas | 37% | 109.05 | 122 / 328 | 43% | 3.52 | 77 / 178 |
ovary | 32% | 92.24 | 57 / 180 | 48% | 3.76 | 205 / 430 |
eye | 0% | 0 | 0 / 0 | 73% | 5.74 | 58 / 80 |
lymph node | 0% | 0 | 0 / 0 | 69% | 6.27 | 20 / 29 |
peripheral blood | 69% | 756.34 | 640 / 929 | 0% | 0 | 0 / 0 |
muscle | 32% | 92.51 | 255 / 803 | 0% | 0 | 0 / 0 |
adipose | 31% | 85.91 | 378 / 1204 | 0% | 0 | 0 / 0 |
heart | 31% | 85.45 | 268 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 16% | 43.57 | 215 / 1335 | 0% | 0 | 0 / 0 |
liver | 3% | 8.25 | 6 / 226 | 12% | 0.82 | 48 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0098696 | Biological process | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane |
GO_0099645 | Biological process | neurotransmitter receptor localization to postsynaptic specialization membrane |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0014069 | Cellular component | postsynaptic density |
GO_0035255 | Molecular function | ionotropic glutamate receptor binding |
Gene name | NETO2 |
Protein name | NETO2 protein Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2) Neuropilin and tolloid like 2 |
Synonyms | UNQ1926/PRO4401 BTCL2 |
Description | FUNCTION: Accessory subunit of neuronal kainate-sensitive glutamate receptors, GRIK2 and GRIK3. Increases kainate-receptor channel activity, slowing the decay kinetics of the receptors, without affecting their expression at the cell surface, and increasing the open probability of the receptor channels. Modulates the agonist sensitivity of kainate receptors. Slows the decay of kainate receptor-mediated excitatory postsynaptic currents (EPSCs), thus directly influencing synaptic transmission (By similarity). . |
Accessions | ENST00000563078.1 Q32NC3 ENST00000562435.6 [Q8NC67-1] ENST00000303155.9 [Q8NC67-3] H3BM37 ENST00000564667.1 ENST00000562559.5 H3BTE1 H3BSR0 Q8NC67 |